Altered calcium homeostasis in cells transformed by mitochondria from individuals with Parkinson's disease

Journal of Neurochemistry

Volumn 68, Issue 3, 1997, Pages 1221-1233

  Sheehan, J P ^a   Swerdlow, R H ^a   Parker, W D ^a   Miller, S W ^b   Davis, R E ^b   Tuttle, J B ^a,c  

^a UNIVERSITY OF VIRGINIA   (United States)

^b Migenix Inc   (United States)

^c UNIVERSITY OF VIRGINIA HEALTH SYSTEM   (United States)

Author keywords

Calcium; Mitochondria; Parkinson's disease

Indexed keywords

1 METHYL 4 PHENYLPYRIDINIUM; ADENINE NUCLEOTIDE; ADENOSINE DIPHOSPHATE; ADENOSINE PHOSPHATE; ADENOSINE TRIPHOSPHATE; CALCIUM; CARBACHOL; CARBONYL CYANIDE CHLOROPHENYLHYDRAZONE; LANTHANUM; MITOCHONDRIAL DNA; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE DEHYDROGENASE (UBIQUINONE); SUCCINIC ACID; THAPSIGARGIN;

ADULT; AGED; ARTICLE; CALCIUM CELL LEVEL; CALCIUM HOMEOSTASIS; CELL CULTURE; CELL DEATH; CELL ENERGY; CELL LINE; CELL TRANSFORMATION; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME INHIBITION; FEMALE; FLUORESCENCE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; HUMAN CELL; MALE; MITOCHONDRION; PARKINSON DISEASE; PRIORITY JOURNAL;

EID: 0031017696     PISSN: 00223042     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1471-4159.1997.68031221.x     Document Type: Article

References (78)

1. Agid Y. (1995) Aging, disease and nerve cell death. Bull. Acad. Natl. Med. 179, 1193-1207.
2. Ankarcrona M., Dypbukt J. M., Bonfoco E., Zhivotovsky B., Orrenius S., Lipton S. A., and Nicotera P. (1995) Glutamate-induced neuronal death: a succession of necrosis or apoptosis depending on mitochondrial function. Neuron 15, 961-973.
3. Arroyo C. M. and Forray C. (1991) Activation of cyclic GMP formation in mouse neuroblastoma cells by a labile nitroxyl radical. An electron paramagnetic resonance/spin trapping study. Eur. J. Pharmacol. 208, 157-161.
4. Arroyo C. M., Forray C., El-Fakahany E. E., and Rosen G. M. (1990) Receptor-mediated generation of an EDRF-like intermediate in a neuronal cell line detected by spin trapping techniques. Biochem. Biophys. Res. Commun. 170, 1177-1183.
5. Basavappa S., Chartouni V., Kirk K., Prpic V., Ellory J. C., and Mangel A. W. (1995) Swelling-induced chloride currents in neuroblastoma cells are calcium dependent. J. Neurosci. 15, 3662-3666.
6. Beal M. F., Hyman B. T., and Koroshetz W. (1993) Do defects in mitochondrial energy metabolism underlie the pathology of neurodegenerative diseases? Trends Neurosci. 16, 125-131.
7. Benecke R., Strumper P., and Weiss H. (1993) Electron transfer complexes I and IV of platelets are abnormal in Parkinson's disease but normal in Parkinson-plus syndromes. Brain 116, 1451-1463.
8. 2+ in dissociated type I cells of rabbit carotid body. J. Physiol. (Lond.) 416, 421-434.
9. 2+ concentration measured with specifically targeted recombinant aequorin. EMBO J. 12, 4813-4819.
10. Brini M., Marsault R., Bastianutto C., Pozzan T., and Rizzuto R. (1994) Nuclear targeting of aequorin. Cell Calcium 16, 259-268.
11. Buttgereit F. and Brand M. D. (1995) A hierarchy of ATP-consuming processes in mammalian cells. Biochem. J. 312, 163-167.
12. Chacon E., Ohata H., Harper I. S., Trollinger D. R., Herman B., and Lemasters J. J. (1996) Mitochondrial free calcium transients during excitation-contraction coupling in rabbit cardiac myocytes. FEBS Lett. 382, 31-36.
13. Chiueh C. C., Wu R. M., Mohanakumar K. P., Sternberger L. M., Krishna G., Obata T., and Murphy D. L. (1994) In vivo generation of hydroxyl radicals and MPTP-induced dopaminergic toxicity in the basal ganglia. Ann. NY Acad. Sci. 738, 25-36.
14. Cortopassi G. and Wang E. (1995) Modelling the effects of age-related mtDNA mutation accumulation; complex I deficiency, superoxide and cell death. Biochim. Biophys. Acta 1271, 171-176.
15. DiDonato S., Zeviani M., Giovannini P., Savarese N., Rimoldi M., Mariotti C., Girotti F., and Caraceni T. (1993) Respiratory chain and mitochondrial DNA in muscle and brain in Parkinson's disease patients. Neurology 43, 2262-2268.
16. DiMonte D. A., Wu E. Y., Delanney L. E., Irwin I., and Langston J. W. (1992) Toxicity of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine in primary cultures of mouse astrocytes. J. Pharmacol. Exp. Ther. 261, 44-49.
17. 2+ removal in smooth muscle cells. Pflugers Arch. 431, 473-482.
18. Duchen M. R., Valdeolmillos M., O'Neill S. C., and Eisner D. A. (1990) Effects of metabolic blockade on the regulation of intracellular calcium in dissociated mouse sensory neurons. J. Physiol. (Lond.) 424, 411-426.
19. +: implications for neurodegeneration. J. Neurochem. 37, 584-591.
20. 2+]. J. Neurosci. 14, 4007-4024.
21. Garrahan P. J. and Rega A. F. (1990) Plasma membrane calcium pump, in Intracellular Calcium Regulation (Bronner F., ed), pp. 271-303. Alan R. Liss, New York.
22. Gerlach M., Riederer P., Przuntek H., and Youdim M. B. H. (1991) MPTP mechanisms of neurotoxicity and their implications for Parkinson's disease. Eur. J. Pharmacol. 208, 273-286.
23. Ghosh A. and Greenberg M. E. (1995) Calcium signaling in neurons: molecular mechanisms and cellular consequences. Science 268, 239-247.
24. Greenberg M.S. (1994) Handbook of Neurosurgery, pp. 74-78. Greenberg Graphics, Lakeland, Florida.
25. 2+ indicators with greatly improved fluorescence properties. J. Biol. Chem. 260, 3440-3450.
26. Haas R. H., Nasirian F., Nakano K., Ward D., Pay M., Hill R., and Shults C. W. (1995) Low platelet mitochondrial complex I and complex II/III activity in early untreated Parkinson's disease. Ann. Neurol. 37, 714-722.
27. Hassouna I., Wickert H., Zimmermann M., and Gillardon F. (1996) Increase in BAX expression in substantia nigra following 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) treatment of mice. Neurosci. Lett. 204, 85-88.
28. Hekman C., Matsuno-Yagi A., and Hatefi Y. (1988) Energy-induced modulation of the kinetics of oxidative phosphorylation and reverse electron transfer. Biochemistry 27, 7559-7565.
29. 2+ loads from rat adrenal chromaffin cells. Neuron 16, 219-228.
30. Hoehn M. M. and Yahr M. D. (1967) Parkinsonism: onset, progression, and mortality. Neurology 17, 427-442.
31. Ikebe S., Tanaka M., and Ozawa T. (1995) Point mutations of mitochondrial genome in Parkinson's disease. Brain Res. Mol. Brain Res. 28, 281-295.
32. Jouaville L. S., Ichas F., Holmuhamedov E. L., Camacho P., and Lechleiter J. D. (1995) Synchronization of calcium waves by mitochondrial substrates in Xenopus laevis oocytes. Nature 377, 438-441.
33. Kane J. J., Murphy M. L., Bissett J. K., deSoyza N., Doherty J. E., and Straub K. D. (1975) Mitochondrial function, oxygen extraction, epicardial S-T segment changes and tritiated digoxin distribution after reperfusion of ischemic myocardium. Am. J. Cardiol. 36, 218-224.
34. Khan A. A., Soloski M. J., Sharp A. H., Schilling G., Sabatini D. M., Li S. H., Ross C. A., and Snyder S. H. (1996) Lymphocyte apoptosis: mediation by increased type 3 inositol 1,4,5-triphosphate receptor. Science 273, 503-507.
35. 2+ dependent endonuclease associated with apoptosis. J. Immunol. 156, 922-931.
36. Kimura J., Noma A., and Irisawa H. (1986) Na-Ca exchange current in mammalian heart cells. Nature 319, 596-597.
37. King M. P. and Attardi G. (1989) Human cells lacking mtDNA: repopulation with exogenous mitochondria by complementation. Science 246, 500-503.
38. Krige D., Carroll M. T., Cooper J. M., Marsden C. D., and Schapira A. H. (1992) Platelet mitochondrial function in Parkinson's disease. Ann. Neurol. 32, 782-788.
39. Lad P. M., Glovsky M. M., Richards J. H., Smiley P. A., and Backstrom B. (1985) Regulation of human neutrophil guanylate cyclase by metal ions, free radicals and the muscarinic cholinergic receptor. Mol. Immunol. 22, 731-739.
40. Langston J. W., Ballard P. A., Tetrud J. W., and Irwin I. (1983) Chronic parkinsonism in humans due to a product of meperidine-analog synthesis. Science 219, 979-980.
41. Levick V., Coffey H., and D'Mello S. R. (1995) Opposing effects of thapsigargin on the survival of developing cerebellar granule neurons in culture. Brain Res. 676, 325-335.
42. Marchetti P., Susin S. A., Decaudin D., Gamen S., Castedo M., Hirsch T., Zamazami N., Naval J., Senik A., and Kroemer G. (1996) Apoptosis-associated derangement of mitochondrial function in cells lacking mitochondrial DNA. Cancer Res. 56, 2033-2038.
43. Mattson M. P., Zhang Y., and Bose S. (1993) Growth factors prevent mitochondrial dysfunction, loss of calcium homeostasis, and cell injury, but not ATP depletion in hippocampal neurons deprived of glucose. Exp. Neurol. 121, 1-13.
44. Meghji P., Tuttle J. B., and Rubio R. (1989) Adenosine formation and release by embryonic chick neurons and glia in cell culture. J. Neurochem. 53, 1852-1860.
45. Melnick R. L. and Schiller C. M. (1985) Effect of phthalate esters on energy coupling and succinate oxidation in rat liver mitochondria. Toxicology 34, 13-27.
46. 2+ regulation in aging neurons. Ann. NY Acad. Sci. 747, 407-418.
47. Miller S. W., Davis R. E., Trimmer P. A., and Parker W. D. (1996) Creation and characterization of mitochondrial DNA depleted cell lines with "neuronal-like" properties. J. Neurochem. 67, 1897-1907.
48. Mytilineou C., Werner P., Molinari S., DiRocco A., Cohen G., and Yahr M. D. (1994) Impaired oxidative decarboxylation of pyruvate in fibroblasts from patients with Parkinson's disease. J. Neural Transm. Park. Dis. Dement. (Sect.) 8, 223-228.
49. Naarala J., Nykvist P., Tuomala M., and Savolainen K. (1993) Excitatory amino acid-induced slow biphasic responses of free intracellular calcium in human neuroblastoma cells. FEBS Lett. 330, 222-226.
50. Nicklas W. J. and Heikkila R. E. (1985) Inhibition of NADH-linked oxidation in brain mitochondria by 1-methyl-4-phenylpyridine, a metabolite of the neurotoxin, 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine. Life Sci. 36, 2503-2508.
51. 2+ and cell death. Ann. NY Acad. Sci. 648, 17-27.
52. 2+ level. J. Immunol. 154, 599-609.
53. +) and nitric oxide simultaneously causes cyclosporin A-sensitive mitochondrial calcium efflux and depolarisation. Biochem. Pharmacol. 51, 267-273.
54. 2+ clearance mechanisms in isolated rat adrenal chromaffin cells. J. Physiol. (Lond.) 492, 329-346.
55. Parker W. D., Boyson S. J., and Parks J. K. (1989a) Abnormalities of the electron transport chain in idiopathic Parkinson's disease. Ann. Neurol. 26, 719-723.
56. Parker W. D., Oley C. A., and Parks J. K. (1989b) A defect in mitochondrial electron-transport activity (NADH-coenzyme Q oxidoreductase) in Leber's hereditary optic neuropathy. N. Engl. J. Med. 320, 1331-1333.
57. 3+ influx in ventricular cells by indo-1 fluorescence. Am. J. Physiol. 256, C351-C357.
58. Powis D. A., Clark C. L., and O'Brien K. J. (1994) Lanthanum can be transported by the sodium-calcium exchange pathway and directly triggers catecholamine release from bovine chromaffin cells. Cell Calcium 16, 377-390.
59. Pozzan T., Rizzuto R., Volpe P., and Meldolesi J. (1994) Molecular and cellular physiology of intracellular calcium stores. Physiol. Rev. 74, 595-636.
60. 2+: their relationship to apoptosis and oncogenesis. FEBS Lett. 325, 104-107.
61. 2+ revealed by specifically targeted recombinant aequorin. Nature 358, 325-327.
62. 3-sensitive channels that are sensed by neighboring mitochondria. Science 262, 744-747.
63. 2+ homeostasis in intact cells. J. Cell Biol. 126, 1183-1194.
64. Schagger H., Diekmann S., and Ohm T. G. (1995) Oxphos protein defects in Alzheimer's disease, in Parkinson's disease and in mitochondrial encephalomyopathies revealed by blue native electrophoresis. Soc. Neurosci. Abstr. 21, 1492.
65. Schapira A. H. V. (1994) Mitochondrial dysfunction in neurodegenerative disorders and aging, in Mitochondrial Disorder in Neurology (Schapira A. H. V. and DiMauro S., eds), pp. 227-244. Butterworth-Heinemann Ltd., Oxford.
66. Schapira A. H., Mann V. M., Cooper J. M., Krige D., Jenner P. J., and Marsden P. J. (1992) Mitochondrial function in Parkinson's disease. Ann. Neurol. 32, S116-S124.
67. Schweizer F. E., Betz H., and Augustine G. J. (1995) From vesicle docking to endocytosis: intermediate reaction of exocytosis. Neuron 14, 689-696.
68. Shryock J. C., Rubio R., and Berne R. (1986) Extraction of adenine nucleotides from cultured endothelial cells. Anal. Biochem. 159, 73-81.
69. Swerdlow R. H., Parks J. K., Miller S. W., Tuttle J. B., Trimmer P. A., Sheehan J. P., Bennett J. P., Davis R. E., and Parker W. D. (1996) Origin and functional consequences of the complex I defect in Parkinson's disease. Ann. Neurol. 40, 663-671.
70. Takehara Y., Kanno T., Yoshioka T., Inoue M., and Utsumi K. (1995) Oxygen-dependent regulation of mitochondrial energy metabolism by nitric oxide. Arch. Biochem. Biophys. 323, 27-32.
71. Thayer S. A. and Miller R. J. (1990) Regulation of the intracellular free calcium concentration in single rat dorsal root ganglion neurones in vitro. J. Physiol. (Lond.) 425, 85-115.
72. Thomas D. and Hanley M. R. (1994) Pharmacological tools for perturbing intracellular calcium storage, in Methods in Cell Biology. Vol. 40: A Practical Guide to the Study of Calcium in Living Cells (Nuccitelli R., ed), pp. 65-89. Academic Press, San Diego.
73. Thomas L. B., Gates D. J., Richfield E. K., O'Brien T. F., Schweitzer J. B., and Steindler D. A. (1995) DNA end labeling (TUNEL) in Huntington's disease and other neuropathological conditions. Exp. Neurol. 133, 265-272.
74. Tong J. X., Eichler M. E., and Rich K. M. (1996) Intracellular calcium levels influence apoptosis in mature sensory neurons after trophic factor deprivation. Exp. Neurol. 138, 45-52.
75. Tritschler H. J., Packer L., and Medori R. (1994) Oxidative stress and mitochondrial dysfunction in neurodegeneration. Biochem. Mol. Biol. Int. 34, 169-181.
76. Uitei K., Sato S., Miyake T., and Miyata Y. (1996) Induction of apoptosis in a Drosophila neuronal cell line by calcium ionophore. Neurosci. Lett. 203, 191-194.
77. Werth J. L. and Thayer S. A. (1994) Mitochondria buffer physiological calcium loads in cultured rat dorsal root ganglion neurons. J. Neurosci. 14, 348-356.
78. 2+ exchange buffer glutamate-induced calcium loads in cultured cortical neurons. J. Neurosci. 15, 1318-1328.